Option Care Health’s (OPCH) “Outperform” Rating Reiterated at Barrington Research

Option Care Health (NASDAQ:OPCH)‘s stock had its “outperform” rating reiterated by equities research analysts at Barrington Research in a research note issued on Wednesday, Benzinga reports. They currently have a $40.00 price target on the stock. Barrington Research’s price target indicates a potential upside of 33.11% from the stock’s current price.

Separately, JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $0.29 during mid-day trading on Wednesday, reaching $30.05. 690,357 shares of the stock were exchanged, compared to its average volume of 1,399,906. The stock has a market capitalization of $5.22 billion, a P/E ratio of 19.77, a P/E/G ratio of 2.21 and a beta of 1.29. Option Care Health has a 1 year low of $26.11 and a 1 year high of $34.63. The company has a 50 day simple moving average of $31.08 and a 200-day simple moving average of $30.11. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The business had revenue of $1.23 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the firm posted $0.63 earnings per share. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. Analysts anticipate that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Option Care Health

Large investors have recently modified their holdings of the business. Harbor Capital Advisors Inc. increased its position in Option Care Health by 317.9% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after purchasing an additional 73,312 shares in the last quarter. Comerica Bank raised its position in shares of Option Care Health by 6.5% in the first quarter. Comerica Bank now owns 760,915 shares of the company’s stock valued at $25,521,000 after buying an additional 46,639 shares during the last quarter. Janus Henderson Group PLC lifted its stake in shares of Option Care Health by 182.9% during the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after buying an additional 146,837 shares during the period. Edgestream Partners L.P. boosted its position in Option Care Health by 96.8% during the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after acquiring an additional 172,845 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in Option Care Health in the 2nd quarter worth approximately $973,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.